SEE ALSO:
Communicable Diseases
COVID-19
Healthcare-Associated Infections (HAI)
Influenza (Flu)
Legionella
Mpox
Mosquito-Borne Diseases
One Health
Tick-borne Diseases
Toxicology
Viral Hemorrhagic Fevers
NEED HELP?
Having trouble finding what you are looking for? Use our A to Z Index.
Case Counts
The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year.
|
Cases Reported Year-to-Date* |
Totals by Year Reported |
||||||
Condition |
2025 |
2024 |
% Change |
2024 |
2023 |
2022 |
2021 |
2020 |
Acute Flaccid Myelitis |
0 | 0 | -- | 0 | 0 | 1 | 1 | 0^ |
Anthrax |
0 | 0 | -- | 0^ | 0 | 0 | 0 | 0 |
Arboviral Diseases (excludes Chikungunya virus, Dengue, and Zika virus) |
1 | 0 | 100.0% | 36 | 32 | 5 | 12 | 10 |
Babesiosis |
0 | 2 | -100.0% | 4^ | 1 | 0 | 1 | 1 |
Botulism |
0 | 0 | -- | 1 | 2 | 2 | 0 | 1 |
Brucellosis |
0 | 0 | -- | 0^ | 0 | 0 | 1 | 1 |
Campylobacteriosis |
558 | 511 | 9.2% | 1153 | 878 | 813 | 745 | 665 |
Chikungunya virus - travel related, acquired out of state |
0 | 0 | -- | 0 | 1 | 0 | 0 | 0 |
Cholera |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Coccidioidomycosis |
4 | 5 | -20.0% | 10 | 12 | 12 | 13 | 5 |
Cryptosporidiosis |
66 | 80 | -17.5% | 248 | 213 | 158 | 125 | 138 |
Cyclosporiasis |
2 | 1 | 100.0% | 30 | 140 | 19 | 6 | 9 |
Dengue - travel related, acquired out of state |
1 | 3 | -66.7% | 11 | 5 | 5 | 1 | 0 |
E. coli, shiga toxin-producing (includes O157: H7) |
76 | 81 | -6.2% | 163 | 170 | 159 | 138 | 100 |
Ehrlichiosis/Anaplasmosis |
7 | 6 | 16.7% | 13 | 5 | 10 | 24 | 12 |
Hansen's Disease (Leprosy) |
1 | 0 | 100.0% | 0 | 2 | 0 | 0 | 1 |
Hemolytic uremic syndrome (HUS) |
3 | 0 | 300.0% | 1 | 6 | 10 | 3 | 3 |
Influenza-associated pediatric mortality |
2 | 1 | 100.0% | 1 | 1 | 3 | 0 | 1 |
Legionellosis |
41 | 36 | 13.9% | 81 | 66 | 65 | 89 | 61 |
Listeriosis |
7 | 4 | 75.0% | 8 | 16 | 12 | 12 | 14 |
Lyme disease |
11 | 18 | -38.9% | 38 | 34 | 32 | 51 | 15 |
Malaria - travel related, acquired out of state |
0 | 2 | -200.0% | 9 | 11 | 8 | 8 | 2 |
Novel Influenza A virus infection |
0 | 0 | -- | 0^ | 0 | 0 | 0 | 0 |
Paratyphoid Fever |
1 | 1 | 00.0% | 7 | 0 | 2 | 2 | 1 |
Plague |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0^ |
Primary Amebic Meningoencephalitis (Naegleria fowleri) |
0 |
0 |
-- |
0^ |
0 |
0 |
0 |
0 |
Q fever |
0 | 0 | -- | 1 | 2 | 3 | 2 | 0 |
Rabies, animal |
15 | 13 | 15.4% | 28 | 38^ | 45 | 44 | 51 |
Rabies, human |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Salmonellosis |
363 | 351 | 3.4% | 1093 | 879 | 996 | 861 | 891 |
Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV) |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Shigellosis |
62 | 65 | -4.6% | 125 | 100 | 81 | 88 | 346 |
Smallpox |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Spotted Fever Rickettsiosis |
35 | 31 | 12.9% | 72 | 81 | 118 | 121 | 90 |
Trichinellosis (Trichinosis) |
0 | 0 | -- | 0 | 0 | 1 | 0 | 0 |
Tularemia |
0 | 0 | -- | 1 | 1 | 3 | 0 | 1 |
Typhoid fever |
0 | 0 | -- | 1 | 2 | 0 | 3 | 1 |
Vibriosis (non-Cholera) |
18 | 19 | -5.3% | 54 | 37 | 41 | 34 | 26 |
Viral hemorrhagic fever |
0 | 0 | -- | 0^ | 0 | 0 | 0 | 0 |
VISA (Staphylococcus aureus, vancomycin-intermediate) |
1 | 0 | 100.0% | 1 | 1 | 1 | 1 | 0 |
VRSA (Staphylococcus aureus, vancomycin-resistant) |
3 | 1 | 200.0% | 1 | 0 | 0 | 1 | 1 |
Yellow Fever |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Zika virus - travel related, acquired out of state |
0 | 0 | -- | 0 | 0 | 0 | 0 | 0 |
Other Investigations |
1 | 2 | -50% | 2 | 5 | 0 | 1 | 0 |
Total |
1279 | 1234 | 3.6% | 3193 | 2741 | 2604 | 2389 | 2447 |
NOTE: Counts include finalized investigations among Alabama residents as of July 1, 2025. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS. |
||||||||
*Through MMWR Week 26 (week ending June 28, 2025), as compared to the same time period in the previous calendar year. |
||||||||
^The case definition was updated this year for this condition. |
Page last updated: July 2, 2025
SEE ALSO:
Communicable Diseases
COVID-19
Healthcare-Associated Infections (HAI)
Influenza (Flu)
Legionella
Mpox
Mosquito-Borne Diseases
One Health
Tick-borne Diseases
Toxicology
Viral Hemorrhagic Fevers
NEED HELP?
Having trouble finding what you are looking for? Use our A to Z Index.